{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:19:56Z","timestamp":1762543196310},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s10633-020-09764-1","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T10:24:37Z","timestamp":1585736677000},"page":"195-204","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Improvement of reduced electroretinographic responses in thymoma-associated retinopathy: a case report and literature review"],"prefix":"10.1007","volume":"141","author":[{"given":"Kei","family":"Mizobuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Katagiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Euido","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutsugu","family":"Ishiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumiko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,1]]},"reference":[{"key":"9764_CR1","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/0002-9394(76)90125-2","volume":"81","author":"RA Sawyer","year":"1976","unstructured":"Sawyer RA, Selhorst JB, Zimmerman LE, Hoyt WF (1976) Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol 81:606\u2013613","journal-title":"Am J Ophthalmol"},{"key":"9764_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1568-9972(02)00127-1","volume":"2","author":"G Adamus","year":"2003","unstructured":"Adamus G (2003) Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy. Autoimmun Rev 2:63\u201368","journal-title":"Autoimmun Rev"},{"key":"9764_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2415-4-5","volume":"4","author":"G Adamus","year":"2004","unstructured":"Adamus G, Ren G, Weleber RG (2004) Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol 4:5. https:\/\/doi.org\/10.1186\/1471-2415-4-5","journal-title":"BMC Ophthalmol"},{"key":"9764_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00281-008-0114-7","volume":"30","author":"JR Heckenlively","year":"2008","unstructured":"Heckenlively JR, Ferreyra HA (2008) Autoimmune retinopathy: a review and summary. Semin Immunopathol 30:127\u2013134. https:\/\/doi.org\/10.1007\/s00281-008-0114-7","journal-title":"Semin Immunopathol"},{"key":"9764_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ajo.2013.09.019","volume":"157","author":"L Grange","year":"2014","unstructured":"Grange L, Dalal M, Nussenblatt RB, Sen HN (2014) Autoimmune retinopathy. Am J Ophthalmol 157:266\u2013272.e261. https:\/\/doi.org\/10.1016\/j.ajo.2013.09.019","journal-title":"Am J Ophthalmol"},{"key":"9764_CR6","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/archophthalmol.2009.24","volume":"127","author":"HA Ferreyra","year":"2009","unstructured":"Ferreyra HA, Jayasundera T, Khan NW, He S, Lu Y, Heckenlively JR (2009) Management of autoimmune retinopathies with immunosuppression. Arch Ophthalmol 127:390\u2013397. https:\/\/doi.org\/10.1001\/archophthalmol.2009.24","journal-title":"Arch Ophthalmol"},{"key":"9764_CR7","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1097\/iae.0000000000000119","volume":"34","author":"DS Grewal","year":"2014","unstructured":"Grewal DS, Fishman GA, Jampol LM (2014) Autoimmune retinopathy and antiretinal antibodies: a review. Retina 34:827\u2013845. https:\/\/doi.org\/10.1097\/iae.0000000000000119","journal-title":"Retina"},{"key":"9764_CR8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/archopht.117.4.471","volume":"117","author":"J Guy","year":"1999","unstructured":"Guy J, Aptsiauri N (1999) Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases. Arch Ophthalmol 117:471\u2013477","journal-title":"Arch Ophthalmol"},{"key":"9764_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11060-006-9326-7","volume":"83","author":"L Espandar","year":"2007","unstructured":"Espandar L, O\u2019Brien S, Thirkill C, Lubecki LA, Esmaeli B (2007) Successful treatment of cancer-associated retinopathy with alemtuzumab. J Neurooncol 83:295\u2013302. https:\/\/doi.org\/10.1007\/s11060-006-9326-7","journal-title":"J Neurooncol"},{"key":"9764_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s12348-012-0067-9","volume":"2","author":"N Huynh","year":"2012","unstructured":"Huynh N, Shildkrot Y, Lobo AM, Sobrin L (2012) Intravitreal triamcinolone for cancer-associated retinopathy refractory to systemic therapy. J Ophthalmic Inflamm Infect 2:169\u2013171. https:\/\/doi.org\/10.1007\/s12348-012-0067-9","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"9764_CR11","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/j.jcjo.2012.11.010","volume":"48","author":"C Or","year":"2013","unstructured":"Or C, Collins DR, Merkur AB, Wang Y, Chan CC, Forooghian F (2013) Intravenous rituximab for the treatment of cancer-associated retinopathy. Can J Ophthalmol 48:e35\u2013e38. https:\/\/doi.org\/10.1016\/j.jcjo.2012.11.010","journal-title":"Can J Ophthalmol"},{"key":"9764_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0039-6257(02)00416-2","volume":"48","author":"JW Chan","year":"2003","unstructured":"Chan JW (2003) Paraneoplastic retinopathies and optic neuropathies. Surv Ophthalmol 48:12\u201338","journal-title":"Surv Ophthalmol"},{"key":"9764_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0002-9394(02)01598-2","volume":"134","author":"H Katsuta","year":"2002","unstructured":"Katsuta H, Okada M, Nakauchi T, Takahashi Y, Yamao S, Uchida S (2002) Cancer-associated retinopathy associated with invasive thymoma. Am J Ophthalmol 134:383\u2013389","journal-title":"Am J Ophthalmol"},{"key":"9764_CR14","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0046-8177(03)00183-7","volume":"34","author":"G Yamada","year":"2003","unstructured":"Yamada G, Ohguro H, Aketa K, Itoh T, Shijubo N, Takahashi H, Fujiwara O, Satoh M, Ohtsuka K, Abe S (2003) Invasive thymoma with paraneoplastic retinopathy. Hum Pathol 34:717\u2013719","journal-title":"Hum Pathol"},{"key":"9764_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1755-3768.2008.01456.x","volume":"88","author":"G Querques","year":"2010","unstructured":"Querques G, Thirkill CE, Hagege H, Soubrane G, Souied EH (2010) Choroidal neovascularization associated with cancer-associated retinopathy. Acta Ophthalmol 88:571\u2013575. https:\/\/doi.org\/10.1111\/j.1755-3768.2008.01456.x","journal-title":"Acta Ophthalmol"},{"key":"9764_CR16","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1167\/iovs.13-11868","volume":"54","author":"Y Makiyama","year":"2013","unstructured":"Makiyama Y, Kikuchi T, Otani A, Oishi A, Guo C, Nakagawa S, Ogino K, Kojima H, Kurimoto M, Yoshimura N (2013) Clinical and immunological characterization of paraneoplastic retinopathy. Invest Ophthalmol Vis Sci 54:5424\u20135431. https:\/\/doi.org\/10.1167\/iovs.13-11868","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9764_CR17","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/bjo.2008.151563","volume":"94","author":"A Tanaka","year":"2010","unstructured":"Tanaka A, Takase H, Adamus G, Mochizuki M (2010) Cancer-associated retinopathy caused by benign thymoma. Br J Ophthalmol 94:526\u2013528. https:\/\/doi.org\/10.1136\/bjo.2008.151563","journal-title":"Br J Ophthalmol"},{"key":"9764_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3109\/09273948.2012.730652","volume":"21","author":"CK Wan","year":"2013","unstructured":"Wan CK, Teoh SC (2013) Autoimmune retinopathy in benign thymoma after good syndrome-associated cytomegalovirus retinitis. Ocul Immunol Inflamm 21:79\u201381. https:\/\/doi.org\/10.3109\/09273948.2012.730652","journal-title":"Ocul Immunol Inflamm"},{"key":"9764_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-014-9473-7","volume":"130","author":"DL McCulloch","year":"2015","unstructured":"McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R, Bach M (2015) ISCEV Standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol 130:1\u201312. https:\/\/doi.org\/10.1007\/s10633-014-9473-7","journal-title":"Doc Ophthalmol"},{"key":"9764_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3109\/13816810.2014.991931","volume":"37","author":"S Katagiri","year":"2016","unstructured":"Katagiri S, Hayashi T, Kondo M, Tsukitome H, Yoshitake K, Akahori M, Ikeo K, Tsuneoka H, Iwata T (2016) RPE65 mutations in two Japanese families with Leber congenital amaurosis. Ophthalmic Genet 37:161\u2013169. https:\/\/doi.org\/10.3109\/13816810.2014.991931","journal-title":"Ophthalmic Genet"},{"key":"9764_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s10633-019-09679-6","author":"T Kutsuma","year":"2019","unstructured":"Kutsuma T, Katagiri S, Hayashi T, Yoshitake K, Iejima D, Gekka T, Kohzaki K, Mizobuchi K, Baba Y, Terauchi R, Matsuura T, Ueno S, Iwata T, Nakano T (2019) Novel biallelic loss-of-function KCNV2 variants in cone dystrophy with supernormal rod responses. Doc Ophthalmol. https:\/\/doi.org\/10.1007\/s10633-019-09679-6","journal-title":"Doc Ophthalmol"},{"key":"9764_CR22","doi-asserted-by":"publisher","first-page":"e19911","DOI":"10.1371\/journal.pone.0019911","volume":"6","author":"M Kondo","year":"2011","unstructured":"Kondo M, Sanuki R, Ueno S, Nishizawa Y, Hashimoto N, Ohguro H, Yamamoto S, Machida S, Terasaki H, Adamus G, Furukawa T (2011) Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction. PLoS ONE 6:e19911. https:\/\/doi.org\/10.1371\/journal.pone.0019911","journal-title":"PLoS ONE"},{"key":"9764_CR23","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","volume":"48","author":"A Masaoka","year":"1981","unstructured":"Masaoka A, Monden Y, Nakahara K, Tanioka T (1981) Follow-up study of thymomas with special reference to their clinical stages. Cancer 48:2485\u20132492. https:\/\/doi.org\/10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","journal-title":"Cancer"},{"key":"9764_CR24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/1521-4141(200102)31:2<563::AID-IMMU563>3.0.CO;2-D","volume":"31","author":"A Maeda","year":"2001","unstructured":"Maeda A, Ohguro H, Nabeta Y, Hirohashi Y, Sahara H, Maeda T, Wada Y, Sato T, Yun C, Nishimura Y, Torigoe T, Kuroki Y, Sato N (2001) Identification of human antitumor cytotoxic T lymphocytes epitopes of recoverin, a cancer-associated retinopathy antigen, possibly related with a better prognosis in a paraneoplastic syndrome. Eur J Immunol 31:563\u2013572. https:\/\/doi.org\/10.1002\/1521-4141(200102)31:2<563::AID-IMMU563>3.0.CO;2-D","journal-title":"Eur J Immunol"},{"key":"9764_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/s0952523800003175","volume":"10","author":"AH Milam","year":"1993","unstructured":"Milam AH, Dacey DM, Dizhoor AM (1993) Recoverin immunoreactivity in mammalian cone bipolar cells. Vis Neurosci 10:1\u201312. https:\/\/doi.org\/10.1017\/s0952523800003175","journal-title":"Vis Neurosci"},{"key":"9764_CR26","first-page":"81","volume":"34","author":"AS Polans","year":"1993","unstructured":"Polans AS, Burton MD, Haley TL, Crabb JW, Palczewski K (1993) Recoverin, but not visinin, is an autoantigen in the human retina identified with a cancer-associated retinopathy. Invest Ophthalmol Vis Sci 34:81\u201390","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9764_CR27","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/s0002-9394(98)00149-4","volume":"126","author":"SM Whitcup","year":"1998","unstructured":"Whitcup SM, Vistica BP, Milam AH, Nussenblatt RB, Gery I (1998) Recoverin-associated retinopathy: a clinically and immunologically distinctive disease. Am J Ophthalmol 126:230\u2013237. https:\/\/doi.org\/10.1016\/s0002-9394(98)00149-4","journal-title":"Am J Ophthalmol"},{"key":"9764_CR28","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.cell.2010.02.015","volume":"140","author":"L Zitvogel","year":"2010","unstructured":"Zitvogel L, Kepp O, Kroemer G (2010) Decoding cell death signals in inflammation and immunity. Cell 140:798\u2013804. https:\/\/doi.org\/10.1016\/j.cell.2010.02.015","journal-title":"Cell"},{"key":"9764_CR29","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.ophtha.2012.07.008","volume":"120","author":"N Yoshida","year":"2013","unstructured":"Yoshida N, Ikeda Y, Notomi S, Ishikawa K, Murakami Y, Hisatomi T, Enaida H, Ishibashi T (2013) Laboratory evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. Ophthalmology 120:e5\u201312. https:\/\/doi.org\/10.1016\/j.ophtha.2012.07.008","journal-title":"Ophthalmology"},{"key":"9764_CR30","doi-asserted-by":"publisher","first-page":"14598","DOI":"10.1073\/pnas.1206937109","volume":"109","author":"Y Murakami","year":"2012","unstructured":"Murakami Y, Matsumoto H, Roh M, Suzuki J, Hisatomi T, Ikeda Y, Miller JW, Vavvas DG (2012) Receptor interacting protein kinase mediates necrotic cone but not rod cell death in a mouse model of inherited degeneration. Proc Natl Acad Sci U S A 109:14598\u201314603. https:\/\/doi.org\/10.1073\/pnas.1206937109","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-020-09764-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10633-020-09764-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-020-09764-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T23:44:02Z","timestamp":1617234242000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10633-020-09764-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["9764"],"URL":"https:\/\/doi.org\/10.1007\/s10633-020-09764-1","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,1]]},"assertion":[{"value":"10 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest regarding this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were carried out in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statements of human rights"}},{"value":"Informed consent was obtained from the patient included in this report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures conformed to the Association for Research in Vision and Ophthalmology statement for the Use of Animals in Ophthalmic and Vision Research. All procedures were approved by the Institutional Safety Committee on Recombinant DNA Experiments and the Animal Experimental Committees of the Institute for Protein Research at Osaka University.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement on the welfare of animals"}}]}}